The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)
Showing 1-11 of 11 articles
Timing of bioprosthetic valve fracture in transcatheter valve-in-valve intervention: impact on valve durability and leaflet integrity
Meier D,
Payne G,
Mostaço-Guidolin L,
Bouchareb R,
Rich C,
Lai A,
Chatfield A,
Akodad M,
Salcudean H,
Lutter G,
Puehler T,
Pibarot P,
Allen K,
Chhatriwalla A,
Sondergaard L,
Wood D,
Webb J,
Leipsic J,
Sathananthan J,
Sellers S
February 20, 2023 | 10.4244/EIJ-D-22-00644
Timing of bioprosthetic valve fracture in transcatheter valve-in-valve intervention: impact on valve durability and leaflet integrity
Meier D,
Payne G,
Mostaço-Guidolin L,
Bouchareb R,
Rich C,
Lai A,
Chatfield A,
Akodad M,
Salcudean H,
Lutter G,
Puehler T,
Pibarot P,
Allen K,
Chhatriwalla A,
Sondergaard L,
Wood D,
Webb J,
Leipsic J,
Sathananthan J,
Sellers S
September 18, 2022 | 10.4244/EIJ-D-22-00644
Repeat transcatheter aortic valve implantation and implications for transcatheter heart valve performance: insights from bench testing
Sathananthan J,
Fraser R,
Landes U,
Rich C,
Sellers S,
Leipsic J,
Blanke P,
Lutter G,
Frank D,
Puehler T,
Wood D,
Søndergaard L,
Webb J
November 19, 2021 | 10.4244/EIJ-D-20-00697
“Minimalist” transcatheter aortic valve implantation during the COVID-19 pandemic: previously optional but now a necessity
August 7, 2020 | 10.4244/EIJV16I6A82
A bench test study of bioprosthetic valve fracture performed before versus after transcatheter valve-in-valve intervention
Sathananthan J,
Fraser R,
Hatoum H,
Barlow A,
Stanová V,
Allen K,
Chhatriwalla A,
Rieu R,
Pibarot P,
Dasi L,
Søndergaard L,
Wood D,
Webb J
March 20, 2020 | 10.4244/EIJ-D-19-00939
Impact of implant depth on hydrodynamic function with the ACURATE neo transcatheter heart valve following valve-in-valve transcatheter aortic valve replacement in Mitroflow bioprosthetic valves: an ex vivo bench study
Sathananthan J,
Sellers S,
Fraser R,
Dvir D,
Hensey M,
Murdoch D,
Blanke P,
Pibarot P,
Toggweiler S,
Wood D,
Leipsic J,
Webb J
May 20, 2019 | 10.4244/EIJ-D-18-00947
First-in-human experience of a new-generation transfemoral transcatheter aortic valve for the treatment of severe aortic regurgitation: the J-Valve transfemoral system
Hensey M,
Murdoch D,
Sathananthan J,
Alenezi A,
Sathananthan G,
Moss R,
Blanke P,
Leipsic J,
Wood D,
Cheung A,
Ye J,
Webb J
February 7, 2019 | 10.4244/EIJ-D-18-00935
Latest news
AHEAD OF PRINT
Design of the TARGET-FIRST randomised study
FREE ARTICLE - Giuseppe Tarantini et al
March 31, 2023
AHEAD OF PRINT
Oesophageal and gastric injuries in tricuspid TEER
FREE ARTICLE - Tanja Kuecken et al
March 29, 2023
AHEAD OF PRINT
Heavily calcified CTOs: an expert review from the European CTO Club
FREE ARTICLE - Kambis Mashayekhi et al
March 27, 2023
NEW ISSUE
ESC/EAPCI Consensus Statement on Renal Denervation; the Future of TMVR; Mini-focus on Interventional Pharmacology...
March 20, 2023
AHEAD OF PRINT
Diagnostic accuracy of OFR
FREE ARTICLE - Fukang Hu et al
March 23, 2023
AHEAD OF PRINT
Contemporary transcatheter prostheses in small annuli
FREE ARTICLE - Pier Pasquale Leone et al
March 21, 2023
AHEAD OF PRINT
Early changes in cardiac damage after TAVI
FREE ARTICLE - Yaoyao Zhou et al
March 17, 2023